Lv3
270 积分 2024-08-07 加入
JAK inhibitor selectivity: new opportunities, better drugs?
4小时前
已完结
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization
2个月前
已完结
JAK-STAT in lipid metabolism of adipocytes
3个月前
已完结
Macrophage polarization and diabetic wound healing
3个月前
已完结
Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection
4个月前
已完结
Fragment-to-Lead Medicinal Chemistry Publications in 2019
4个月前
已完结
The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise‐Induced Asthma and Leads to Suppression of LPS‐Stimulated TNF‐α Ex Vivo
5个月前
已完结
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
5个月前
已完结
Orphan Drugs and Rare Diseases
5个月前
已完结
Ruxolitinib
5个月前
已完结
皖公网安备34019202002308
